Skip to main content
Clinical Trials/ISRCTN15978506
ISRCTN15978506
Completed
未知

Randomized clinical trial evaluating the effect on many molecular markers well established as atherosclerosis/cardiovascular risk factors of moderate different alcoholic beverages consumption on healthy subjects.

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)0 sites42 target enrollmentNovember 1, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Atherosclerosis
Sponsor
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Enrollment
42
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2022 Results article in https://doi.org/10.1016/j.clnesp.2022.10.014 (added 05/12/2022)

Registry
who.int
Start Date
November 1, 2019
End Date
November 18, 2020
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged over 18 years
  • 2\. Able to drink alcohol
  • 3\. Able to abstain from alcohol for 1 week

Exclusion Criteria

  • 1\. Established cardiovascular disease, defined as documented atherosclerosis, previous cardiovascular event, myocardial revascularization, heart failure
  • 2\. Chronic use of corticosteroids, non\-anti\-inflammatory steroidal drugs (NSAIDs), statins, oral hypoglycemic agents, insulins, anticoagulants or antiplatelet agents
  • 3\. Inability to sign the free and informed consent form
  • 4\. History of alcoholism or inability to remain abstinent for the period established in the study
  • 5\. Refusal to drink alcohol for the period established
  • 6\. Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials